The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, registrational-intent, multicenter Phase 2b trial of ACR-368 in ...
L&T Technology Services (BSE: 540115, NSE: LTTS), through its Smart World business, has joined the Arizona Technology Council (AZTC) to expand its global reach in cutting-edge smart city and digital ...
Adriana Dias and co-authors report a low-cost bioassay for the detection of low concentrations of lead in drinking water. The approach uses a genetically modified strain of Escherichia coli, which ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver ...